MODTX — Modus Therapeutics Holding AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK32.47m
- SEK21.10m
Annual cashflow statement for Modus Therapeutics Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.7 | -18 | -16.4 | -15.8 | -18.1 |
| Changes in Working Capital | 4.61 | -3.72 | -0.283 | 1.16 | 0.066 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -16.1 | -21.7 | -16.7 | -14.7 | -18.1 |
| Other Investing Cash Flow Items | -0.05 | 0 | 0 | 0 | 0 |
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.05 | 0 | 0 | 0 | 0 |
| Financing Cash Flow Items | -3.69 | 0 | -1.04 | 0 | 25.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 29.4 | 11.5 | 25.3 | 0 | 25.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13.3 | -10.2 | 8.64 | -14.7 | 6.99 |